Navigation Links
MedReps Survey Reveals Best Places to Work in Medical Sales in 2017
Date:1/10/2017

A recent survey by MedReps (http://www.medreps.com/), a job board for medical sales representatives, revealed Medtronic, Johnson & Johnson, and Stryker as the overall best medical sales companies to work for this year.

The 6th Annual Best Places to Work in Medical Sales survey, which polled more than 1,200 members of the MedReps community, also provides insight about the qualities and values medical sales representatives find most important in a potential employer, including strong product line, competitive compensation, brand recognition, and commitment to innovation, research, and development.

“Most of our respondents said they prefer to sell medical devices or equipment, so it’s no surprise we found Medtronic and Stryker as two of the top three,” said Karyn Mullins, Executive Vice President and General Manager at MedReps. “To make the report even more useful, this year, we broke the best places to work down into three categories -- medical device, pharmaceutical, and biotech -- helping job seekers successfully focus on their best career path.”

Notable findings from the survey include:

  • Medtronic was ranked as the overall best medical sales company to work for, with Johnson & Johnson and Stryker ranked as second and third, respectively.
  • The majority of respondents (68 percent) said they would prefer to work for a small or medium-sized company.
  • Most respondents (72%) listed competitive compensation as one of the top two things they look for from an employer. However, sales professionals also want employers to focus on work-life balance. More than half of respondents (53%) listed work-life balance in the top two.
  • Half of respondents (50%) say a strong product line is the most important quality in an employer.
  • While 70 percent of survey respondents said they are very or somewhat satisfied with their jobs, less than half (45%) said they are very or somewhat likely to leave their job in the next year.

“Medical sales professionals have a multitude of options when it comes to deciding on where to work,” Mullins said. “That’s why we encourage job seekers to never give up on finding a company with a culture and product line they believe in.”

For more information from this survey, click here: https://www.medreps.com/medical-sales-careers/best-places-to-work/.

About MedReps
MedReps is owned and operated by Healthcare Staffing Technologies. As the leading job site in its niche, MedReps gives members access to the most sought after medical sales jobs and pharmaceutical sales jobs on the web. Members have access to approximately 8,000 jobs and can apply directly to the recruiters and hiring managers who post them. For more information on the No. 1 site for medical sales, marketing, and management careers, please visit MedReps.com.

Read the full story at http://www.prweb.com/releases/2017/01/prweb13952419.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. MedReps.com Report Highlights Power of Mobile Medical Sales Job Search
2. MedReps.com Survey Reveals Best Places to Work in Medical Sales in 2014
3. MedReps.com Report Shows Biotech Workers Earn the Most in Medical Sales
4. Worldwide Clinical Trials Reveals Findings of Unique Multinational Survey of Site Preferences for eCOA Technologies
5. Health Connexions & Ascentii Announce a RoleFit Survey™ Global Expansion: A Groundbreaking Innovation for Employers to Identify the Best-Matched “A-List” of Candidates
6. National Survey On Use Of Peppermint Oil In Irritable Bowel Syndrome (IBS) Corroborates Observations From Previous Meta Analysis And American College Of Gastroenterology (ACG) Monograph
7. Now Open: iLab Solutions’ Sixth Annual Core Facility Management Benchmarking Survey
8. Surveyed physicians report that acute kidney injury (AKI) is difficult to manage
9. New Insights on Elective Single Embryo Transfer from Nationwide IVF Patient Survey to be presented at the American Society for Reproductive Medicine
10. As Affordable Care Act Extends Support for Transgender Surgery, Survey Finds Denying Care Has Costs for Insurers, Public
11. WebMD and Medscape Surveys Explore Health Issues Facing Children, Parents and Physicians in Upcoming School Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2020)... , ... August 06, 2020 , ... ... vaccine industries, announces it has closed on the purchase of greenfield for a ... Conroe, TX and includes over 21 acres in the initial acquisition, with an ...
(Date:7/31/2020)... ... 29, 2020 , ... R3 Stem Cell International is now offering patients the ... stem cells total, patients may choose which extremities they would like treated. , Several ... Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced ... materials for use with CRM, neurostimulation, vascular, and related devices. , Anomet ... design requirements, performance, and cost criteria; especially where solid wire is limited. Typical ...
(Date:7/31/2020)... ... 2020 , ... The SDX® Respiratory Gating System , ... reached its 20th anniversary of worldwide use. Introduced in the US over the ... University of Pennsylvania, University of Michigan, University of Maryland, University of California San ...
Breaking Biology Technology:
(Date:7/18/2020)... ... ... Commercial launch readiness is a critical stage in a product life cycle. While ... global economic downturn will only increase price pressures overall for the industry. The era ... from every product launch is critical. However, history shows that only a third of ...
(Date:7/2/2020)... FREDERICK, Md. (PRWEB) , ... ... ... company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the ... a one-step reverse transcription polymerase chain reaction (RT-PCR) in 16 minutes. The ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
Breaking Biology News(10 mins):